8-K//Current report
Inmune Bio, Inc. 8-K
Accession 0001213900-25-119217
$INMBCIK 0001711754operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:00 PM ET
Size
211.0 KB
Accession
0001213900-25-119217
Documents
- 8-Kea0268667-8k_inmune.htmPrimary
CURRENT REPORT
- EX-4.1ea026866701ex4-1_inmune.htm
AMENDMENT NO. 5 TO RIGHTS AGREEMENT, DATED AS OF DECEMBER 5, 2025, BETWEEN THE COMPANY AND VSTOCK TRANSFER LLC, AS RIGHTS AGENT
- EX-101.SCHinmb-20251205.xsd
XBRL SCHEMA FILE
- EX-101.LABinmb-20251205_lab.xml
XBRL LABEL FILE
- EX-101.PREinmb-20251205_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-119217-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0268667-8k_inmune_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001711754
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:00 PM ET
- Size
- 211.0 KB